Early Insights From Clinical Trials of Typhoid Conjugate Vaccine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32725230.
- Also identified by DOI 10.1093/cid/ciaa370 and PMC identifier 7388715.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.
Medical subject headings
- Typhoid Fever
- Typhoid-Paratyphoid Vaccines